RILPONLIA Trademark

Trademark Overview

On Thursday, June 25, 2026, a trademark application was filed for RILPONLIA with the United States Patent and Trademark Office. The USPTO has given the RILPONLIA trademark a serial number of 99905635. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, June 26, 2026. This trademark is owned by AstraZeneca AB. The RILPONLIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes
rilponlia

General Information

Serial Number99905635
Word MarkRILPONLIA
Filing DateThursday, June 25, 2026
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, June 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 25, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSodertalje SE-15185
SE

Trademark Events

Event DateEvent Description
Thursday, June 25, 2026NEW APPLICATION ENTERED
Thursday, June 25, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 25, 2026APPLICATION FILING RECEIPT MAILED
Friday, June 26, 2026ASSIGNED TO EXAMINER
Friday, June 26, 2026SUSPENSION LETTER WRITTEN
Friday, June 26, 2026LETTER OF SUSPENSION E-MAILED
Friday, June 26, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

rilponlia pharmaceutical preparations disorders diseases treatment hematological infection inflammation autoimmune antibodies